NCT04391322View on ClinicalTrials.gov

Assessment of CFTR-Modulator Treatment in Cystic Fibrosis Lung Disease Using Novel Structural and Functional MRI

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 20, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Group 1: Healthy ControlsGroup 2: Stable CFGroup 3: CF Participants Anticipated to Receive CFTR-modulator TherapyGroup 4: 4-8 yo CF Participants Starting Triple Combination Modulator Therapy

Trial Locations (1)

M5G 1X8

RECRUITING

The Hospital for Sick Children, Toronto

All Listed Sponsors

lead

The Hospital for Sick Children

OTHER